• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Partnerships

Our partners

Home > Partnerships

Our partners

  • Our partners
  • Partnering with us

Collaboration is an essential part of DNDi’s virtual R&D model: we cannot carry out our work without the engagement of public and private partners.

Today, DNDi has forged a diverse range of alliances and research collaborations with over 200 partners and service providers in nearly 50 countries.

Industry partners and service providers
Universities and research centres
Non-profit organizations, NGOs, and networks
Healthcare providers
Ministries of health and governments

Ministries of health and governments

Loading…
Africa CDC

Africa

Loading…
Loading…
test image
Centre for Disease Control and Prevention (CDC)

USA

Loading…
4-in-1 (ABC/3TC/LPV/r) /
Loading…
test image
Centre Pour Le Développement Des Vaccins, Ministry of Health

Mali

Loading…
ANTICOV /
Loading…
test image
Chagas Programme of Santa Cruz

Bolivia

Loading…
Chagas Access Project /
Loading…
test image
CSIR-Central Drug Research Institute (CSIR-CDRI)

India

Loading…
Loading…
Pandemic Preparedness /
test image
Department of Science and Technology, South Africa

South Africa

Loading…
Super-booster therapy /
Loading…
test image
Drug Regulatory Authorities, Ethiopia

Ethiopia

Loading…
LEAP Platform /
Loading…
test image
Drug Regulatory Authorities, Kenya

Kenya

Loading…
LEAP Platform /
Loading…
test image
Drug Regulatory Authorities, Sudan

Sudan

Loading…
LEAP Platform /
Loading…
test image
Drug Regulatory Authorities, Uganda

Uganda

Loading…
LEAP Platform /
Loading…
test image
Federal Bureau of Health, Ethiopia

Ethiopia

Loading…
LEAP Platform /
Loading…
test image
Federal Ministry of Health South Sudan

South Sudan

Loading…
Fexinidazole for T.b. gambiense /
Loading…
test image
Goiás State Department of Health

Brazil

Loading…
Chagas Access Project /
Loading…
test image
Guatemala Chagas Programme

Guatemala

Loading…
Chagas Access Project /
Loading…
test image
Health Area Direction of Jalapa

Guatemala

Loading…
Chagas Access Project /
Loading…
test image
Health Area Direction of Jutiapa

Guatemala

Loading…
Chagas Access Project /
Loading…
test image
Health Secretary of Santader

Colombia

Loading…
Chagas Access Project /
Loading…
test image
Health secretary of Soatá

Colombia

Loading…
Chagas Access Project /
Loading…
test image
Ministère des Affaires Sociales et de la Santé Sénégal

Senegal

Loading…
4-in-1 (ABC/3TC/LPV/r) /
Loading…
test image
Ministério da Saúde Brasil

Brazil

Loading…
Chagas Access Project /
Paediatric Benznidazole /
redeLEISH Network /
Loading…
test image
Ministério de Salud, Província de Jujuy

Argentina

Loading…
Paediatric Benznidazole /
Loading…
test image
Ministry of Health (Bolivia)

Bolivia

Loading…
Chagas Access Project /
New benznidazole regimens /
Loading…
test image
Ministry of Health and Child Care Zimbabwe

Zimbabwe

Loading…
Loading…
Paediatric HIV /
test image
Ministry of Health and Family Welfare Bangladesh

Bangladesh

Loading…
New VL treatments (South Asia) /
Loading…
test image
Ministry of Health Argentina

Argentina

Loading…
New benznidazole regimens /
Paediatric Benznidazole /
Loading…
test image
Ministry of Health Brazil, Leishmaniasis Control Programme

Brazil

Loading…
New VL treatments (Latin America) /
Loading…
test image
Ministry of Health Burkina Faso

Burkina Faso

Loading…
4-in-1 (ABC/3TC/LPV/r) /
Loading…
test image
Ministry of Health Colombia

Colombia

Loading…
Chagas Access Project /
redeLEISH Network /
Loading…
test image
Ministry of Health Ethiopia, Neglected Tropical Disease Directorate

Ethiopia

Loading…
Miltefosine + Paromomycin combination (Africa) /
SSG&PM (East Africa) /
VL-0208 /
Loading…
test image
Ministry of Health Ghana

Ghana

Loading…
ASAQ /
Loading…
test image
Ministry of Health Guatemala

Guatemala

Loading…
Chagas Access Project /
Loading…
test image
Ministry of Health Ivory Coast

Côte d’Ivoire

Loading…
Loading…
Filaria: river blindness /
test image
Ministry of Health Kenya

Kenya

Loading…
2-in-1 LPV/r pellets and ABC/3TC or AZT/3TC /
4-in-1 (ABC/3TC/LPV/r) /
LEAP Platform /
Miltefosine + Paromomycin combination (Africa) /
SSG&PM (East Africa) /
VL-0208 /
Loading…
test image
Ministry of Health Kenya, Neglected Tropical Diseases Unit, Leishmaniasis Programme

Kenya

Loading…
Loading…
Visceral leishmaniasis /
test image
Ministry of Health Malawi

Malawi

Loading…
Fexinidazole for T.b. rhodesiense /
Loading…
test image
Ministry of Health Malaysia

Malaysia

Loading…
Dengue Alliance /
Hepatitis C Screening in Malaysia – #MYmissingmillions /
Pre-clinical profiling /
Ravidasvir + sofosbuvir /
Loading…
Hepatitis C /
test image
Ministry of Health Sudan, Neglected Tropical Diseases Unit, Leishmaniasis Programme

Sudan

Loading…
LEAP Platform /
Miltefosine + Paromomycin combination (Africa) /
New treatments for PKDL (Eastern Africa) /
SSG&PM (East Africa) /
VL-0208 /
Loading…
test image
Ministry of Health Tanzania

Tanzania

Loading…
4-in-1 (ABC/3TC/LPV/r) /
Loading…
Paediatric HIV /
test image
Ministry of Health Uganda

Uganda

Loading…
4-in-1 (ABC/3TC/LPV/r) /
Loading…
test image
Ministry of Health Uganda, Leishmaniasis Control Programme

Uganda

Loading…
LEAP Platform /
SSG&PM (East Africa) /
VL-0208 /
Loading…
test image
Ministry of Health, Sierra Leone

Sierra Leone

Loading…
ASAQ /
Loading…
test image
Ministry of Public Health Cameroon

Cameroon

Loading…
4-in-1 (ABC/3TC/LPV/r) /
Loading…
test image
Ministry of Public Health DRC

DRC

Loading…
4-in-1 (ABC/3TC/LPV/r) /
Flubentylosin /
Loading…
test image
Ministry of Public Health Thailand

Thailand

Loading…
Ravidasvir + sofosbuvir /
Loading…
test image
National Control Programme of the Republic of the Congo

Republic of the Congo

Loading…
Nifurtimox-eflornithine combination therapy (NECT) /
Loading…
test image
National Department of Health South Africa

South Africa

Loading…
2-in-1 LPV/r pellets and ABC/3TC or AZT/3TC /
4-in-1 (ABC/3TC/LPV/r) /
Super-booster therapy /
Loading…
test image
National HAT Control Programme (PNLTHA) Guinea

Guinea

Loading…
ACOZI-KIDS /
Acoziborole /
Capacity development to facilitate access to fexinidazole /
Fexinidazole for T.b. gambiense /
Loading…
test image
National HAT Control Programme of the Democratic Republic of Congo (PNLTHA)

DRC

Loading…
ACOZI-KIDS /
Acoziborole /
Capacity development to facilitate access to fexinidazole /
Fexinidazole for T.b. gambiense /
Nifurtimox-eflornithine combination therapy (NECT) /
Loading…
test image
National HAT Control Programmes of the Central African Republic

Central African Republic

Loading…
Fexinidazole for T.b. gambiense /
Loading…
test image
National Institute to Combat and Control Trypanosomiasis (ICCT), Ministry of Health of Angola

Angola

Loading…
Fexinidazole for T.b. gambiense /
Loading…
test image
National Kala-azar Elimination Program (NKEP)

Bangladesh

Loading…
LeishAccess /
Loading…
test image
National Malaria Control Programme, Ministry of Health Burundi

Burundi

Loading…
ASAQ /
Loading…
test image
National Pharmacovigilance Center, Ministry of Health of Morocco

Morocco

Loading…
Fexinidazole for T.b. gambiense /
Loading…
test image
National Science and Technology Development Agency (NSTDA)

Thailand

Loading…
Ravidasvir + sofosbuvir /
Loading…
test image
National sleeping sickness control programmes, research institutions, and national laboratories of public health of the most affected endemic countries: Angola, Central African Republic, Chad, Democratic Republic of the Congo, Guinea, Republic of Congo, South Sudan, Sudan, Uganda
Loading…
HAT Platform /
Loading…
test image
National Vector Borne Disease Control Programme, India

India

Loading…
LXE408 Novartis for VL /
New VL treatments (South Asia) /
Loading…
test image
Programa Nacional de Leishmaniasis Colombia

Colombia

Loading…
Miltefosine + thermotherapy for cutaneous leishmaniasis /
Loading…
test image
Programme National de Lutte contre les Maladies Non Transmissibles

Benin

Loading…
Loading…
Filaria: river blindness /
test image
Programme National de Lutte contre les Maladies Tropicales Négligées (PNLMTN)

DRC

Loading…
Flubentylosin /
Loading…
test image
Programme national de lutte contre les Maladies Tropicales Négligées à Chimiothérapie Préventive

Côte d’Ivoire

Loading…
Loading…
Filaria: river blindness /
test image
Programme national de lutte contre les maladies tropicales négligées à chimiothérapie préventive (PNLMTN-CTP)

DRC

Loading…
Emodepside /
Flubentylosin /
Loading…
test image
Public Health Promotion Research and Training Thailand

Thailand

Loading…
Loading…
Hepatitis C /
test image
Responsable Programa de Chagas – Ministerio de Salud

Bolivia

Loading…
Chagas Access Project /
Loading…
test image
Secretaría de Salud departamental de Boyacá

Colombia

Loading…
Chagas Access Project /
Loading…
test image
Secretaría de Salud, Protección y Bienestar Social Colombia

Colombia

Loading…
Chagas Access Project /
Loading…
test image
Secretaría de Salud, Protección y Bienestar Social de Mogotes

Colombia

Loading…
Chagas Access Project /
Loading…
test image
Secretaria Municipal de Saúde Unidade Referência em Atenção Primária Drª Claudia Vitorino

Brazil

Loading…
redeLEISH Network /
Loading…
test image
Soatá Town Hall, Boyacá

Colombia

Loading…
Chagas Access Project /
Loading…
test image
Special Administrative Health Unit, Arauca Department

Colombia

Loading…
Chagas Access Project /
Loading…
test image
State Health Society, Bihar

India

Loading…
New VL treatments (South Asia) /
Loading…
test image
Unidad de Enfermedades Infecciosas, Seccion de Salud Internacional y Consejo al Viajero, Spain

Spain

Loading…
Fexinidazole for Chagas /
Loading…
test image
US Food and Drug Administration (FDA)

USA

Loading…
CpG-D35 (DNDI-2319) /
Loading…
test image
Vice-Presidência de Pesquisa e Coleções Biológicas – VPPCB

Brazil

Loading…
Miltefosine + thermotherapy for cutaneous leishmaniasis /
Loading…
test image

Become a partner

Help us bring the best science to the most neglected.

contact us
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License